60 filings
8-K
REVB
Revelation Biosciences Inc
16 May 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
REVB
Revelation Biosciences Inc
10 May 24
Results of Operations and Financial Condition
4:57pm
8-K
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
8-K
REVB
Revelation Biosciences Inc
11 Mar 24
Regulation FD Disclosure
9:53pm
8-K
REVB
Revelation Biosciences Inc
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
8-K
05zp0yd327
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
8-K
n755cojuodpyfi63
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
upmh la6212pm746
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
1jl4yqbs
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
u8mio1pg
12 Oct 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2023 www.revbiosciences.com
4:26pm
8-K
l4n26diilu1jpor9tmh
2 Oct 23
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
4:24pm
8-K
ty6wisqcgqdsb6qdw6ob
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
ir1y6a sxb7j34h
11 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
ktezssw1 336ji
14 Jul 23
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
3vh03 h3pbuvp9
7 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
qihp b9ebc8740f
29 Jun 23
Regulation FD Disclosure
4:23pm
8-K
cwdj6sxrf3vz1kmy
12 Jun 23
Regulation FD Disclosure
4:20pm
8-K
nbrjuamt334vh3nm8u
25 May 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / May 2023 www.revbiosciences.com
4:32pm
8-K
gvflgqth5xnso
22 May 23
Results of Operations and Financial Condition
1:22pm
8-K
ix79sqnzi7a 1yd
3 Apr 23
Results of Operations and Financial Condition
4:33pm